Paul O’Brien, Ph.D.

Senior Research Associate

Paul O’Brien, Ph.D., is a Senior Research Associate in Patient Square Insights. Most recently, Dr. O’Brien was an Associate Director, M&A at BridgeBio Pharma where he evaluated clinical and commercial-stage healthcare opportunities with a focus on therapeutics. Previously, Dr. O’Brien held positions at Point72, Regeneron Pharmaceuticals, and Piper Sandler.

Dr. O’Brien holds a Ph.D. in Biochemistry and Molecular Biophysics from Columbia University, and a Masters in Biotechnology and B.S.E in Chemical and Biomolecular Engineering from the University of Pennsylvania.

Back To Team